Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07811258 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Improving Adherence to Chronic Disease Medication Regimens Among Patients With Recently Diagnosed Cancer

StatusNot Yet Recruiting
PhaseNot applicable
Started2026-09-07
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary endpoint reworded 3 of 9 changed
See other at-risk trials from Duke University

Amendment history

2026-10-02
critical
Primary endpoint(s) modified9 entries, revised
WasAcceptability, as measured by Acceptability of Intervention Measure (AIM), Feasibility, as measured by completion rate of the adherence log, Feasibility, as measured by completion rate of the adherence log, Feasibility, as measured by completion rate of the comprehensive medication review, Feasibility, as measured by number of participants recruited, Feasibility, as measured by screening to enrollment ratio, Patient-centeredness, as measured by the Patient-Centered Care Questionnaire (PCCQ), Patient-centeredness, as measured by the Patient-Centered Outcomes Questionnaire (PCOQ), Usability, as measured by the System Usability Score of the Medisafe application
NowAcceptability, as measured by Acceptability of Intervention Measure, Feasibility, as measured by completion rate of the adherence log, Feasibility, as measured by completion rate of the adherence log, Feasibility, as measured by completion rate of the comprehensive medication review, Feasibility, as measured by number of participants recruited, Feasibility, as measured by screening to enrollment ratio, Patient-centeredness, as measured by the Patient-Centered Care Questionnaire, Patient-centeredness, as measured by the Patient-Centered Outcomes Questionnaire, Usability, as measured by the System Usability Score of the Medisafe application
455 trials monitored
See 53 trials at risk
This pilot study evaluates a pharmacist-led medication adherence intervention and Medisafe mobile application among patients with newly diagnosed cancer and multimorbidity. Thirty participants will be randomized to intervention or usual care to assess feasibility, acceptability, usability, and preliminary efficacy.
Trial Details
NCT Number NCT07811258
Lead Sponsor Duke University
Conditions Cancer
Enrollment 30 participants
Start Date 2026-09-07
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-10-01